A scientist at the University of British Columbia and Vancouver Coastal Health has identified the molecule that controls a scissor-like protein responsible for the production of plaques – the telltale sign of Alzheimer’s disease (AD).
A scientist at the University of British Columbia and Vancouver Coastal Health has identified the molecule that controls a scissor-like protein responsible for the production of plaques – the telltale sign of Alzheimer’s disease (AD).
UBC Neurology Prof. Judy Illes is among 25 international leading researchers recommending the handling of incidental findings in genomic research in a paper published online today in the journal Genetics in Medicine.
A team of researchers at the University of British Columbia has identified a genetic mutation that causes late-onset Parkinson’s disease, paving the way to a new target for potential treatments that may halt or cure the debilitating neurodegenerative disease.
The University of British Columbia today announced a $15 million gift from Vancouver philanthropist Djavad Mowafaghian for a new facility that integrates brain research and patient care. In honour of his generosity – the largest gift to date to the UBC Faculty of Medicine – the facility will be named the Djavad Mowafaghian Centre for Brain Health.
A one-year follow-up study on seniors who participated in a strength training exercise program shows sustained cognitive benefits as well as savings for the healthcare system. The research, conducted at the Centre for Hip Health and Mobility at Vancouver Coastal Health and the University of British Columbia, is published today in the Archives of Internal Medicine.
A specific type of fat present in cell membranes also serves as a cellular pH sensor, a team of University of British Columbia researchers has discovered.
The benefits of marijuana in tempering or reversing the effects of Alzheimer’s disease have been challenged in a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.